Pre-ROSC Intra-Nasal Cooling Effectiveness
PRINCE
Trans-Nasal Cooling With the RhinoChill Device Following Cardiac Arrest: A Pilot Study
1 other identifier
interventional
200
5 countries
15
Brief Summary
The purpose of the study was to demonstrate the safety and feasibility of early intranasal cooling prior to return of spontaneous circulation (ROSC) in the emergency medical services (EMS) environment. It was hypothesized that cooling during the resuscitation attempt would increase ROSC and subsequent survival. The study was not powered to demonstrate statistically-significant differences in any outcome parameter, but was intended as an exploratory study only.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2008
Shorter than P25 for not_applicable
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 11, 2008
CompletedFirst Posted
Study publicly available on registry
December 15, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2009
CompletedResults Posted
Study results publicly available
July 16, 2010
CompletedJune 10, 2011
June 1, 2011
7 months
December 11, 2008
May 21, 2010
June 8, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Achieve Return of Spontaneous Circulation (ROSC)
ROSC was defined as the return of an organized rhythm on electrocardiography (ECG) with a palpable pulse that was maintained for at least 20 minutes.
1-hour after arrest
Survived to Hospital Discharge
The study end-point was hospital discharge. This outcome measure is the patient count for those that were discharged alive from the hospital.
30 days after arrest
Survived Neurologically-Intact
The Cerebral Performance Categories (CPC) are used to describe neurological outcome. A CPC of 1 or 2 is considered "neurologically intact." 1. \- Good cerebral performance: little to no deficit. 2. \- Moderate cerebral disability: capable of independent activities of daily life 3. \- Severe cerebral disability: conscious, but dependent on others for daily support 4. \- Coma or vegetative state 5. \- Death or brain death
30-days after arrest
Secondary Outcomes (5)
Primary Outcomes in Sub-group With VF/VT as First Rhythm
hospital discharge
Time to Therapeutic Temperature
within 8 hours after enrollment
Length of Stay
Hospital Discharge
Serious Adverse Events (SAEs)
7 days after arrest
24-hour Adverse Events (AE)
24 hours after arrest
Study Arms (2)
RhinoChill
EXPERIMENTALIntra-arrest cooling with the RhinoChill during advanced cardiac life support
Control
OTHERAdvanced cardiac life support, only
Interventions
Nasal catheters are placed and cooling is begun during the resuscitation attempt
Advanced cardiac life support according to American Heart Association \& European Resuscitation Council 2005 Guidelines
Eligibility Criteria
You may qualify if:
- ≥18 years
- Collapse was witnessed
- No pulse
- Unresponsive to external stimuli
You may not qualify if:
- Have an etiology of cardiac arrest due to trauma, severe bleeding, drug overdose (OD), cerebrovascular accident (CVA), drowning, smoke inhalation, electrocution, hanging
- Already hypothermic
- Head trauma
- Cannot place intra nasal catheters
- Do Not Attempt to Resuscitate (DNAR) orders
- Known or clinically apparent pregnancy
- Have a known coagulopathy (except therapeutically induced)
- Are known to have a need for supplemental oxygen
- Achieve return of spontaneous circulation (ROSC) prior to initiating cooling
- Are reached by emergency medical services (EMS) personnel more than 20 minutes after collapse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- BeneChill, Inclead
Study Sites (15)
CHU St Pierre
Brussels, 1000, Belgium
Erasme Hospital (Free University of Brussels)
Brussels, 1070, Belgium
CHU de Tivoli
La Louvière, 7100, Belgium
UZ Gasthuisberg Leuven
Leuven, B-3000, Belgium
CHR de la Citadelle
Liège, 4000, Belgium
Helig Hartzieknehuis Roeselare
Roeselare, 8800, Belgium
Faculty Hospital Královské Vinohrady
Prague, 10034, Czechia
Medizinisches Zentrum Kreis Aachen gGmbH
Aachen, 52146, Germany
Charite Campus Virchow Klinikum
Berlin, 13353, Germany
Albert Ludwigs University Freiburg
Freiburg im Breisgau, 79106, Germany
Georg August-Universität Göttingen
Göttingen, 37086, Germany
Krankenhaus Martha-Maria Halle-Dölau gGmbH
Halle, 06120, Germany
Otto-von-Guericke-Universität Magdeburg
Magdeburg, 39120, Germany
A.O Ospedale San Gerardo di Monza
Monza, 20052, Italy
Stockholm Prehospital Centrum
Stockholm, 118 83, Sweden
Related Publications (2)
Tsai MS, Barbut D, Tang W, Wang H, Guan J, Wang T, Sun S, Inderbitzen B, Weil MH. Rapid head cooling initiated coincident with cardiopulmonary resuscitation improves success of defibrillation and post-resuscitation myocardial function in a porcine model of prolonged cardiac arrest. J Am Coll Cardiol. 2008 May 20;51(20):1988-90. doi: 10.1016/j.jacc.2007.12.057. No abstract available.
PMID: 18482670BACKGROUNDCastren M, Nordberg P, Svensson L, Taccone F, Vincent JL, Desruelles D, Eichwede F, Mols P, Schwab T, Vergnion M, Storm C, Pesenti A, Pachl J, Guerisse F, Elste T, Roessler M, Fritz H, Durnez P, Busch HJ, Inderbitzen B, Barbut D. Intra-arrest transnasal evaporative cooling: a randomized, prehospital, multicenter study (PRINCE: Pre-ROSC IntraNasal Cooling Effectiveness). Circulation. 2010 Aug 17;122(7):729-36. doi: 10.1161/CIRCULATIONAHA.109.931691. Epub 2010 Aug 2.
PMID: 20679548DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Becky Inderbitzen, Vice President of Clincial Affairs
- Organization
- BeneChill, Inc.
Study Officials
- STUDY CHAIR
Denise Barbut, MD
BeneChill, Inc
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
December 11, 2008
First Posted
December 15, 2008
Study Start
November 1, 2008
Primary Completion
June 1, 2009
Study Completion
September 1, 2009
Last Updated
June 10, 2011
Results First Posted
July 16, 2010
Record last verified: 2011-06